For most of the past five years, Intel was the chip stock nobody wanted to own. While Nvidia soared into the AI age and AMD captured server market share, Intel posted losses, stumbled on process technology, and watched its stock crater to below $18 in April 2025. Fast forward twelve months, and the story looks almost unrecognisable. Intel has staged one of the most dramatic recoveries in its five-decade history, with shares rising over 240% from their 2025 lows and gaining 76% in 2026 alone — all before a single quarter of profitable results under the new regime has been reported.

So what changed? And more importantly for investors reading this: is there still a rational case to be made, or has the market run too far ahead of the fundamentals?

Three Catalysts That Changed Everything

Intel’s April surge didn’t come from one event — it came from a rapid-fire sequence of strategic announcements that, taken together, suggested the company’s multi-year turnaround was no longer theoretical. Here’s how it unfolded:

Taken together, these four developments transformed how the market perceives Intel’s position in the AI supply chain. Rather than a legacy CPU maker struggling to stay relevant, Intel is now being framed as the only major U.S.-based foundry capable of competing at the leading edge — a geopolitical and industrial asset as much as a technology company.

The Bull Case: Why Long-Term Investors Are Paying Attention

The optimism around Intel isn’t simply hype. There are genuine structural reasons why a successful turnaround could justify significant upside over a multi-year horizon.

The AI inference shift plays to Intel’s strengths. As more companies move from training AI models to deploying them — a process known as inference — demand for CPUs is expected to surge. Intel’s Xeon server business sits squarely in that path. Analysts at Bernstein have forecast 36% year-over-year revenue growth for the Xeon segment in 2026, alongside improving gross margins. Mizuho similarly expects server CPU average selling prices to rise 10–15% this year, driven by AI workload demand — a trend analysts say could persist well into the decade.

The foundry transformation is beginning to show real traction. Intel’s custom ASIC business has crossed a $1 billion annualised run rate, confirming that external foundry customers are beginning to form. The Terafab partnership — if it progresses as announced — would represent the most significant external commitment in the Intel Foundry unit’s history, potentially reshaping the economics of a division that posted a $10.3 billion operating loss in fiscal 2025.

Valuation was genuinely depressed before this rally. Intel traded below $20 less than a year ago. Even at $65, bulls argue the stock is pricing in a realistic — not euphoric — recovery scenario when measured against what the company could look like in 2027 and 2028 if execution holds. Bernstein projects revenue of $57.5 billion and earnings of $1.33 per share in 2027. KeyBanc has a price target of $70. For patient, long-duration investors, the foundry narrative offers something rare: a high-risk, high-reward asymmetric bet on U.S. semiconductor manufacturing leadership.

The Bear Case: Why Wall Street Is Largely Unconvinced

Despite all of the above, the analyst consensus remains stubbornly cautious. As of mid-April 2026, only nine of roughly 48 analysts rate INTC as a Buy, while 33 carry a Hold and six rate it a Sell or Strong Sell. The consensus price target sits around $47–$51 — implying roughly 20–25% downside from current levels.

The numbers don’t yet support the stock price. Intel posted a full-year net loss in fiscal 2025 of approximately $267 million. The Intel Foundry unit alone lost over $10.3 billion operating in FY2025. Q1 2026 guidance calls for revenue of $11.7–$12.7 billion — a sequential decline from Q4’s $13.67 billion — with management guiding to roughly $0.00 non-GAAP EPS in the current quarter. At 126x forward earnings (with some estimates placing the P/E even higher), Intel is being priced for perfection in a business that has spent years falling short of its own forecasts.

Execution risk is material. CEO Lip-Bu Tan himself acknowledged that the transformation “will not happen overnight.” Terafab’s financial terms haven’t been publicly confirmed. The foundry business still requires billions in capital expenditure before it becomes genuinely profitable. And Intel faces fierce competition: TSMC remains the dominant advanced-node foundry globally, while Nvidia, AMD, and Arm are all ramping CPU offerings for the AI inference market that Intel is banking on.

Insider selling raises a yellow flag. Senior executives — including the CLO, CAO, and foundry operations chief — sold shares in the $44–$49 range during the rally, well below current prices. While not necessarily a definitive signal, it adds a note of caution for near-term buyers.

What the Analysts Are Saying

The InvestNotBet Perspective

At InvestNotBet, we don’t chase momentum — we look for the gap between what the market is pricing in and what the underlying business can realistically deliver. Right now, that gap is wide and it cuts both ways.

The bull narrative is not irrational. Intel’s 18A node is genuinely advanced, Terafab is a real and significant partnership, and the geopolitical tailwind for domestic chip manufacturing in the U.S. is durable. If this company executes — and that is a substantial if — the current price may look reasonable in three to five years.

But the bear case is equally grounded in reality. A company trading at 126x forward earnings with negative free cash flow and a foundry unit still losing billions per quarter is not a safe or cheap investment. The stock has run 76% in a single year on announcements, not results. The April 23 earnings report will be the first real accountability moment for a management team that has been making bold promises in an industry notorious for punishing overpromisers.

Our view: Intel is a genuinely interesting speculative position for investors who understand the execution risk and have a 3–5 year horizon. It is not a value play, and it is not a momentum trade for the risk-averse. For those already holding — respect the rally, but tighten your thinking around a stop or trim level. For those considering entry now, waiting for April 23 earnings before committing new capital is the more disciplined approach. Let the results speak.